Indication
Moderate to severe Alzheimer's type dementia
Moderate to severe Alzheimer's type dementia is an advanced clinical stage of a progressive, irreversible neurodegenerative disorder of the central nervous system, predominantly affecting older adults. Read more about Moderate to severe Alzheimer's type dementia
135 drugs 77 manufacturers
Drugs that treat it
Common Moderate to severe Alzheimer's type dementia therapies.
MEMANTINE HCL
MEMANTINE HCL
DONEPEZIL HCL ODT (donepezil HCl)
MEMANTINE HCL
MEMANTINE HCL
MEMANTINE HCL ER (memantine HCl)
MEMANTINE HCL ER (memantine HCl)
MEMANTINE HCL ER (memantine HCl)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonModerate to severe Alzheimer's type dementia is an advanced clinical stage of a progressive, irreversible neurodegenerative disorder of the central nervous system, predominantly affecting older adults.
Neuropathologically, it is driven by widespread cortical deposition of extracellular beta-amyloid plaques and intracellular hyperphosphorylated tau neurofibrillary tangles, leading to extensive synaptic loss, cholinergic deficits, and cerebral atrophy.
In this moderate to severe phase, extensive cognitive deterioration manifests as profound amnesia, aphasia, apraxia, agnosia, and neuropsychiatric symptoms such as agitation, delusions, and wandering.
Affected individuals experience a loss of functional independence, progressing from requiring substantial assistance with instrumental tasks to needing extensive daily care for basic activities of daily living, such as dressing, bathing, and eating.
- medlineplus.gov
Moderate to severe Alzheimer's type dementia is an advanced clinical stage of a progressive, irreversible neurodegenerative disorder of the central nervous system, predominantly affecting older adults
- nih.gov
Moderate to severe Alzheimer's type dementia is an advanced clinical stage of a progressive, irreversible neurodegenerative disorder of the central nervous system, predominantly affecting older adults Neuropathologically, it is driven by widespread cortical deposition of extracellular beta-amyloid plaques and intracellular hyperphosphorylated tau neurofibrillary tangles, leading to extensive synaptic loss, cholinergic deficits, and cerebral atrophy Affected individuals experience a loss of funct...
- mayoclinic.org
Moderate to severe Alzheimer's type dementia is an advanced clinical stage of a progressive, irreversible neurodegenerative disorder of the central nervous system, predominantly affecting older adults Neuropathologically, it is driven by widespread cortical deposition of extracellular beta-amyloid plaques and intracellular hyperphosphorylated tau neurofibrillary tangles, leading to extensive synaptic loss, cholinergic deficits, and cerebral atrophy
- medlineplus.gov
Neuropathologically, it is driven by widespread cortical deposition of extracellular beta-amyloid plaques and intracellular hyperphosphorylated tau neurofibrillary tangles, leading to extensive synaptic loss, cholinergic deficits, and cerebral atrophy In this moderate to severe phase, extensive cognitive deterioration manifests as profound amnesia, aphasia, apraxia, agnosia, and neuropsychiatric symptoms such as agitation, delusions, and wandering
- medlineplus.gov
Neuropathologically, it is driven by widespread cortical deposition of extracellular beta-amyloid plaques and intracellular hyperphosphorylated tau neurofibrillary tangles, leading to extensive synaptic loss, cholinergic deficits, and cerebral atrophy In this moderate to severe phase, extensive cognitive deterioration manifests as profound amnesia, aphasia, apraxia, agnosia, and neuropsychiatric symptoms such as agitation, delusions, and wandering
- alz.org
In this moderate to severe phase, extensive cognitive deterioration manifests as profound amnesia, aphasia, apraxia, agnosia, and neuropsychiatric symptoms such as agitation, delusions, and wandering
- uq.edu.au
In this moderate to severe phase, extensive cognitive deterioration manifests as profound amnesia, aphasia, apraxia, agnosia, and neuropsychiatric symptoms such as agitation, delusions, and wandering Affected individuals experience a loss of functional independence, progressing from requiring substantial assistance with instrumental tasks to needing extensive daily care for basic activities of daily living, such as dressing, bathing, and eating
- medlineplus.gov
Affected individuals experience a loss of functional independence, progressing from requiring substantial assistance with instrumental tasks to needing extensive daily care for basic activities of daily living, such as dressing, bathing, and eating
- alzheimers.org.uk
Affected individuals experience a loss of functional independence, progressing from requiring substantial assistance with instrumental tasks to needing extensive daily care for basic activities of daily living, such as dressing, bathing, and eating
Personalize your experience
Follow Moderate to severe Alzheimer's type dementia and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.